C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
12/2006
12/20/2006	EP1732887A1 1-(1h-indol-1-yl)-3-(4-methylpiperazin-1-yl)-1-phenyl propan-2-ol derivatives and related compounds as modulators of the norepinephrine (ne) and the serotonine (5-ht) activity and the monoamine reuptake for the treatment of vasomotor symptoms (vms)
12/20/2006	EP1732564A1 Biaryl substituted pyrazinones as sodium channel blockers
12/20/2006	EP1188745B1 Heterocyclic dicarboxylic acid diamide derivatives, agricultural/horticultural insecticides and method of using the same
12/20/2006	CN1882550A Acidic bath for electrolytically depositing a copper deposit containing halogenated or pseudohalogenated monomeric phenazinium compounds
12/20/2006	CN1882549A 7-phenylalkyl substituted 2-quinolinones and 2 quinoxalinones as poly(adp-ribose) polymerase inhibitors
12/20/2006	CN1882548A pH sensitive prodrugs of 2,6-diisopropylphenol
12/20/2006	CN1882547A 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
12/20/2006	CN1882542A 2-pyridone derivatives as neutrophil elastase inhibitors and their use
12/20/2006	CN1880313A Novel heterocycle naphthoylimine and double-chain compound and its uses in tumour cell
12/20/2006	CN1290844C Dihydro Indolinone derivatives used as protein kinase inhibitor
12/20/2006	CN1290829C Process of preparing cyclic thioacid amide compound
12/19/2006	US7151178 Reacting 5-methylpyrazinecarboxylic acid with a C1-4 alcohol in acidic cation exchange resin to form the ester, then oxidizing with the potassium monopersulfate in the form of a triple salt 2KHSO5.KHSO4.K2SO4 in a halogenated solvent
12/14/2006	WO2006131835A2 Heterocyclic triazines as hypoxic selective protein kinase inhibitors
12/14/2006	WO2006131192A1 New materials for organic electroluminescence devices
12/14/2006	WO2006105291A3 Heterocyclical chromophore architectures with novel electronic acceptor systems
12/14/2006	US20060281920 such as 6-(4-ethoxy-phenyl)-2S-hydroxy-3R-[4-(3-methoxy-phenyl)-piperazine-1-carbonyl]-hexanoic acid hydroxyamide, used for the treatment or prophylaxis of arthritis in mammals
12/14/2006	US20060281759 selective serotonin receptor antagonists used for the treatment of psychological disorders such as schizophrenia and bipolar disorders, as anxiolytic agents and antidepressants; improved water solubility; side effect reduction;
12/14/2006	US20060281758 used for the treatment of psychological disorders such as schizophrenia, anxiety, depression and bipolar disorder
12/14/2006	US20060281757 Phenyl sulfone derivatives and their use in the treatment of cns disorders
12/14/2006	US20060281734 3-[5-(3-acetamidobenzamido)-2-methylphenyl]-6-(4-methylpiperazin-1-yl)-3,4-dihydroquinazolin-4-one for example; treating rheumatoid arthritis, osteoarthritis, psoriasis, chronic obstructive pulmonary disease; inhibitor of cytokine-mediated disease
12/13/2006	EP1730127A1 Heterocyclic phenylaminopropanol derivatives as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms)
12/13/2006	EP1730123A1 Novel amination process
12/13/2006	EP1294823B1 Double-spiro organic compounds and electroluminescent devices
12/13/2006	CN1878554A 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
12/13/2006	CN1876648A Piperazinylpyrazine compounds as agonists or antagonists of serotonin 5ht-2 receptors
12/13/2006	CN1289499C Pirazino (aza) indole derivatives
12/13/2006	CN1289488C Method of preparing 2-cyanopyrazine by ammonia oxidation method and its special catalyst
12/13/2006	CN1289487C Method for separation and purification of polyhydroxy-alkyl-pyrazine from suger amine reaction liquid
12/13/2006	CN1289471C 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
12/13/2006	CN1289072C Aniline derivatives or salts thereof and cytokine prodn inhibitors containing same
12/12/2006	US7148383 Can be used to prepare elements and devices suitable for use in optical communications
12/12/2006	US7148238 E.g., 4-[2-(4-Methylphenoxy)- or 4-[2-(4-Methylphenylsulfanyl)-phenyl]piperidine or the hydrochloride or oxalate; treating depression, anxiety disorder, and obsessive compulsive disorder.
12/12/2006	US7148225 Treating rheumatoid arthritis, psoriasis, reperfusion injury, cardiovascular , autoimmune, inflammatory disorders and bronchial asthma
12/12/2006	US7148221 Vanilloid receptor ligands and their use in treatments
12/12/2006	CA2378869C Method for making pure stereoisomers of tetrahydrofolic acid ester salts and tetrahydrofolic acid by fractionated crystallisation of tetrahydrofolic acid salts
12/07/2006	WO2006014012A3 Aromatic compounds
12/07/2006	US20060276649 Method for producing ethylene-amines
12/07/2006	US20060276487 New compounds useful for DPP-IV enzyme inhibition
12/07/2006	CA2609355A1 Organic compounds
12/06/2006	CN1875009A Sulfoderivatives of acenaphtho[1,2-b]quinoxaline, lyotropic liquid crystal and anisotropic film on their base
12/06/2006	CN1875002A Phenyl derivatives as PPAR agonists
12/05/2006	US7145039 Transfection reagents
12/05/2006	US7145010 Tert-alkylphenoxy-substituted polycyclic compounds
12/05/2006	US7144897 Substituted amide compound containing hydroxy and amino groups; useful for treating Alzheimer's disease and other similar diseases
12/05/2006	US7144888 Vanilloid receptor ligands and their use in treatments
12/05/2006	US7144886 Dipeptidyl peptidase IV (DP-IV) inhibitors as anti-diabetic agents
12/05/2006	US7144884 E.g., 4-[2-(4-Methylphenoxy)- or 4-[2-(4-Methylphenylsulfanyl)-phenyl]-3,6-dihydro-2H-pyridine or piperazine or the hydrochloride or oxalate; treating depression, anxiety disorder, and obsessive compulsive disorder.
12/05/2006	US7144883 Substituted fused ring sulfonamides containing, e.g., naphthalene, isoquinoline, quinoline, benzofuran or benzothiophene rings; treatment of conditions relating to obesity, type II diabetes and CNS disorders
12/05/2006	US7144882 Central nervous system disorders; psychological disorders; inflammatory bowel disorders
11/2006
11/30/2006	WO2006125337A1 α, β- AND, Ϝ-UNSATURATED CARBOXYLATES AND THE USE AS HERBICIDIDE THEREOF
11/30/2006	US20060270851 Production process of optically pure 2-(4- hydroxyphenoxy)-propionic acid compounds
11/30/2006	US20060270687 Such as n-(4-fluorobenzyl)-6-(4-methyl-1H-imidazol-1-yl)pyrazin-2-amine; protein kinase associated disease states
11/30/2006	US20060270666 Quinoxaline derivatives as neutrophil elastase inhibitors and their use
11/30/2006	CA2610366A1 Selective apoptotic induction in cancer cells including activation of procaspase-3
11/29/2006	EP1725269A1 Catalytic radiofluorination
11/29/2006	CN1871224A 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
11/29/2006	CN1871219A Hexylcarboxanilide
11/29/2006	CN1286837C Method for extracting vitamine B2
11/23/2006	WO2006110173A3 Novel compounds
11/23/2006	WO2006094012A3 Pentacyclic alkaloid compounds and methods of use thereof
11/23/2006	WO2006086107A3 Methods and compositions for minimizing accrual of inhalable insulin in the lungs
11/23/2006	US20060264424 Arylsulfonamidobenzylic compounds
11/22/2006	EP1723128A1 Heteroaryl-ureas and their use as glucokinase activators
11/22/2006	EP1501815B1 Substituted phenylacetamides and their use as glucokinase activators
11/22/2006	EP1458683B1 Heteroaryl-substituted aminocyclohexane derivatives
11/22/2006	EP1351933B1 Il-8 receptor antagonists
11/22/2006	EP1066247B1 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
11/22/2006	EP1051176B1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
11/22/2006	CN1867557A Substitute thiophenes and uses therof
11/22/2006	CN1867554A Piperazine with or-substituted phenyl group and their use as GLYT1 inhibitors
11/21/2006	US7138526 Solid phase synthesis of n,n-disubstituted diazacycloalkylcarboxy derivatives
11/21/2006	US7138407 Phenyl-piperazine derivatives as serotonin reuptake inhibitors
11/21/2006	CA2247257C Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
11/21/2006	CA2140441C Inhibitors of c-amp phosphodiesterase and tnf
11/16/2006	WO2006122238A1 Process for preparing memantine
11/16/2006	WO2006120573A2 Heterocyclic n-oxides as hypoxic selective protein kinase inhibitors
11/16/2006	US20060258866 Carboxylic derivates
11/16/2006	US20060258684 2-[2-[4-[(4-chlorophenyl) phenylmethyl]-1-piperazinyl]ethoxy]acetic acid monohydrochloride as anti-allergenic compound and process for its production
11/16/2006	US20060258683 Para-sulfonyl substituted phenyl compounds as modulators of ppars
11/16/2006	US20060258661 N-(pyridin-2-ylmethyl)-4-methyl-3-oxo-4-aza-5 alpha -androst-1-en-17 beta -acetamide; enhancement of weakened muscle tone; osteoporosis, bone disorders; ; periodontal disease, frailty, aging skin, male hypogonadism, postmenopausal symptoms, inflammatory arthritis, cachexia, Alzheimer's disease
11/16/2006	US20060257613 Metal complexes as light-absorbing compounds in the information layer of optical data carriers
11/15/2006	EP1720878A1 Heteroaryl-fused pyrazolo derivatives
11/15/2006	EP1720847A1 Histamine-3 receptor modulators
11/15/2006	EP1720842A1 Acidic bath for electrolytically depositing a copper deposit containing halogenated or pseudohalogenated monomeric phenazinium compounds
11/15/2006	EP1345942B9 Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists
11/15/2006	EP0968206B1 N-heterocyclic derivatives as nos inhibitors
11/15/2006	CN1863797A Cyclic amine BACE-1 inhibitors having a benzamide substituent
11/15/2006	CN1863782A 2-(quinoxalin-5-ylsulfonylamino)-benzamide compounds as cck2 modulators
11/15/2006	CN1863781A 2-(quinoxalin-5-ylsulfonylamino)-benzamide compounds as cck2 modulators
11/15/2006	CN1284783C Substituted nitrogen contg. heterocycles as inhibitors of P38 progein kinase
11/14/2006	US7135570 Selective hydrogenation of amino-substituted fused bicyclic aromatic ring system, preparation of racemic amino substituted fused bicyclic ring system via nitrosation, enzymatic resolution of racemic mixture to produce (R)- and (S)-forms
11/09/2006	WO2006119451A1 Pyrimidines and pyrazines useful as modulators of ion channels
11/09/2006	US20060252934 For treatment of asthma, allergies, inflammation and anxiety; antihistamines; sedatives; tranquilizing agents
11/09/2006	US20060252767 Piperazine derivatives and their use as therapeutic agents
11/09/2006	CA2603818A1 Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles
11/08/2006	EP1718625A1 Compounds
11/08/2006	EP1718152A2 Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity
11/08/2006	CN1283642C Process for the preparation of highly pure triethylene diamine
11/07/2006	US7132568 beta-amino amides; treating degenerative dementias characterized by beta-amyloid deposits in the brain, especially Alzheimer's Disease
11/07/2006	US7132546 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same

1 ... 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 ... 187